Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
2002. Vitamins, Minerals, Supplements and Dietary Approaches. Focus on Alternative and Complementary Therapies, Vol. 7, Issue. 4, p. 386.
Vaidyanathan, Jaya Bharathi and Walle, Thomas 2003. Cellular Uptake and Efflux of the Tea Flavonoid (-)Epicatechin-3-gallate in the Human Intestinal Cell Line Caco-2. Journal of Pharmacology and Experimental Therapeutics, Vol. 307, Issue. 2, p. 745.
Arab, Lenore and Il'yasova, Dora 2003. The Epidemiology of Tea Consumption and Colorectal Cancer Incidence. The Journal of Nutrition, Vol. 133, Issue. 10, p. 3310S.
Nakachi, Kei Eguchi, Hidetaka and Imai, Kazue 2003. Can teatime increase one’s lifetime?. Ageing Research Reviews, Vol. 2, Issue. 1, p. 1.
Lambert, Joshua D. and Yang, Chung S. 2003. Mechanisms of Cancer Prevention by Tea Constituents. The Journal of Nutrition, Vol. 133, Issue. 10, p. 3262S.
Manning, Jared and Roberts, Jeanette C. 2003. Analysis of Catechin Content of Commercial Green Tea Products. Journal of Herbal Pharmacotherapy, Vol. 3, Issue. 3, p. 19.
Ilʼyasova, D Hodgson, M E Martin, C Galanko, J and Sandler, R S 2003. Tea consumption, apoptosis, and colorectal adenomas. European Journal of Cancer Prevention, Vol. 12, Issue. 5, p. 439.
de Mejía, E.González Ramírez-Mares, M.V. Arce-Popoca, E. Wallig, M. and Villa-Treviño, S. 2004. Inhibition of liver carcinogenesis in Wistar rats by consumption of an aqueous extract from leaves of Ardisia compressa. Food and Chemical Toxicology, Vol. 42, Issue. 3, p. 509.
Boehm, Katja Horneber, Markus Borrelli, Francesca Ernst, Edzard and Boehm, Katja 2004. Cochrane Database of Systematic Reviews.
Su, Lihchyun Joseph and Arab, Lenore 2004. Report: Alcohol Consumption and Risk of Colon Cancer: Evidence From the National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study. Nutrition and Cancer, Vol. 50, Issue. 2, p. 111.
Ramirez-Mares, Marco Vinicio Chandra, Sonia and de Mejia, Elvira Gonzalez 2004. In vitro chemopreventive activity of Camellia sinensis, Ilex paraguariensis and Ardisia compressa tea extracts and selected polyphenols. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 554, Issue. 1-2, p. 53.
Lee, Andy H Fraser, Michelle L and Binns, Colin W 2005. Possible role for green tea in ovarian cancer prevention. Future Oncology, Vol. 1, Issue. 6, p. 771.
Michels, K. B. Willett, W. C. Fuchs, C. S. and Giovannucci, E. 2005. Coffee, Tea, and Caffeine Consumption and Incidence of Colon and Rectal Cancer. JNCI Journal of the National Cancer Institute, Vol. 97, Issue. 4, p. 282.
Milner, John and Jeffery, Elizabeth 2005. Carcinogenic and Anticarcinogenic Food Components. Vol. 20054980, Issue. ,
FINLEY, JOHN W. 2005. Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols and Selenocompounds. Annals of Botany, Vol. 95, Issue. 7, p. 1075.
Cooper, Raymond Morré, D. James and Morré, Dorothy M. 2005. Medicinal Benefits of Green Tea: Part II. Review of Anticancer Properties. The Journal of Alternative and Complementary Medicine, Vol. 11, Issue. 4, p. 639.
Sakakibara, Hiroyuki Ashida, Hitoshi Fukuda, Itsuko Furuyashiki, Takashi Sano, Takashi Nonaka, Yuji Hashimoto, Takashi and Kanazawa, Kazuki 2006. A Frequent Drinking of Green Tea Lowers the Levels of Endogenous Oxidative Stress in Small Intestines, Erythrocytes and Kidneys in Rats. Journal of Clinical Biochemistry and Nutrition, Vol. 39, Issue. 1, p. 32.
Lin, Jennifer Zhang, Shumin M. Wu, Kana Willett, Walter C. Fuchs, Charles S. and Giovannucci, Edward 2006. Flavonoid Intake and Colorectal Cancer Risk in Men and Women. American Journal of Epidemiology, Vol. 164, Issue. 7, p. 644.
Sun, Can-Lan Yuan, Jian-Min Koh, Woon-Puay and Yu, Mimi C. 2006. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis, Vol. 27, Issue. 7, p. 1301.
Bigelow, R L H and Cardelli, J A 2006. The green tea catechins, (−)-Epigallocatechin-3-gallate (EGCG) and (−)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene, Vol. 25, Issue. 13, p. 1922.